Navigation Links
Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants

ment of schizophrenia including maintaining stability in adults who had been symptomatically stable on other antipsychotic medications for periods of three months or longer and observed for relapse during a period of up to 26 weeks. Aripiprazole is also indicated for the treatment of acute manic and mixed episodes associated with Bipolar I Disorder, and for maintaining efficacy in adults with Bipolar I Disorder with a recent manic or mixed episode who had been stabilized and then maintained for at least six (6) weeks. Physicians who elect to use aripiprazole for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual. Aripiprazole Injection is indicated for the treatment of agitation in adults with schizophrenia or bipolar disorder, manic or mixed.

Initially approved in November 2002, over 10 million prescriptions have been written for aripiprazole in the U.S.(5)

Aripiprazole is available by prescription only. Aripiprazole is available in tablets, orally disintegrating tablets, oral solution, and injection for intramuscular use.

Patients should talk to their healthcare professional for more information about aripiprazole.

IMPORTANT SAFETY INFORMATION:

Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk (1.6 to 1.7 times) of death compared to placebo (4.5% vs 2.6%, respectively). Aripiprazole is not approved for the treatment of patients with dementia-related psychosis (see Boxed WARNING).

     - Neuroleptic malignant syndrome (NMS)-As with all antipsychotic

       medications, a rare and potentially fatal condition known as NMS has

       been reported with aripiprazole. NMS can cause hyperpyrexia, muscle

       rigidity, diaphoresis, tachycardia, irregular pulse or blood pressure,

       cardiac dysrhythmia, and altered mental status. If signs and symptoms

       appear, immediate discontinuation is recom
'"/>




Page: 1 2 3 4 5 6 7 8 

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral
Anticoagulant, Presented Today at the XXIst Congress of the
International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial
Combination Therapy with Januvia (sitagliptin) and Metformin Led to
Improvement in Markers of Beta Cell Function in Patients with Type
2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational
Use of Januvia and Metformin as Initial Combination Therapy
Provided Significant Glucose Lowering Efficacy over 54 Weeks in
Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical
Improvement with Orencia (Abatacept) in Children with Juvenile
Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly
Improved Migraine Pain on Several Efficacy Measures in a Phase II
Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational
Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients
With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational
Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational
Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in
Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine
Extended Release, An Investigational Nonstimulant Medication Filed
for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:5/21/2013)... 21, 2013  NxStage Medical, Inc. (Nasdaq: ... today announced that it has entered into new agreements ... products to DaVita, the kidney care division of DaVita Healthcare ... For the use of products for home ... NxStage has executed a second amended and restated National ...
(Date:5/21/2013)... N.Y., May 21, 2013  Lakeland Industries, Inc. ... manufacturer of industrial protective clothing for industry, municipalities, ... and local levels, today announced that the Company ... a Senior Credit Facility subject to certain terms ... this financing.  However, no assurances can be given ...
(Date:5/21/2013)... mayo de 2013 La junta directiva ... incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, ... junta. Guy Mayer, un ejecutivo ortopédico experimentado, será vicepresidente ... Johnson , un experto refutado en dispositivos ... de unirse a OSI como presidente de la ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
(Date:5/21/2013)... 2013 ContinuCare Home Health, Inc. recently ... Aging and Disability Services. After completing a four-day review ... ContinuCare Home Health was found to have no deficiencies ... of the Department of Aging and Disability Services’ mission ... services, supports and opportunities that are easily accessed ...
(Date:5/21/2013)... 21, 2013 Artisan Business Group ... Summit: Dealmakers Conference in Long Beach, California on ... on exploring alternative finance through EB-5 immigrant investors ... legal and economic information, and updates to project ... within the EB-5 industry. , "Our goal ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Focus, a non-profit organization striving to improve the living ... Corridor region, is releasing results for its 2013 Creative ... May 23rd at 10:30 a.m. The survey follows ... The survey is a critical component to the organizations’ ... and retain people of diverse backgrounds, cultures and beliefs ...
(Date:5/21/2013)... Colo. (May 21, 2013) A paper recently published ... and co-written by physicians and scientists at the University ... genetic risk factor for pulmonary fibrosis can be used ... disease. , Researchers looked at a fairly common variant ... a component of the mucous produced by the bronchial ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... Cord Blood America, Inc., (OTC Bulletin Board: CBAI) ( ... has selected Somerville Associates, a 25 year-old public relations ... counsel for Cord Blood America, Inc., according to Matthew ... The agency will publicize Cord Blood America in ...
... Anthem Blue Cross implemented an across-the-board increase in Californai Medicare ... senior citizens to look for new ways to maximize healthcare ... ... Los Angeles, CA (PRWEB) March 20, 2009 -- Anthem Blue ...
... Reflex Plus surgical microscope from Endure Medical, Inc. represents a new ... ... March 20, 2009 -- Endure Medical ( www.enduremed.com ) has created ... excellent optical quality, exceptional red reflex and a price that is ...
... and also have an abnormality in the heart,s electrical cycle ... than people who do not have abnormal electrical activity at ... The study also provides a threshold at which the threat ... in women and 438 milliseconds in men have the worst ...
... Silver 2009 ADDY® Award for its multi-media drug education and prevention campaign ... public service announcements. , ... Los Angeles, Ca (PRWEB) March 19, 2009 ... to 60 seconds in duration, brings home the stark reality of what ...
... 20 , - On Average a ... and Poland Claim Worsening Quality of Sleep,Thanks to the Economy(1) , ... Making the Admission, Compared,to 17% of the UK(1) , ... Problems Sleeping,Over the Last 12 Months, but Only 19% of These ...
Cached Medicine News:Health News:Cord Blood America, Inc. Appoints Somerville Associates, Public Relations Counsel 2Health News:Seniors Seek to Reduce Healthcare Costs as Anthem Blue Cross Increases Premiums 2Health News:Endure Medical Redefines Ophthalmic Surgical Microscopes 2Health News:Abnormal EKG can predict death in stroke patients 2Health News:Foundation for the Drug-Free World Honored with Seven ADDY Awards 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 2Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 3Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 4Health News:New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep 5
... xenon illumination for High ... instruments. Port allows use ... cables. Worldwide voltage and ... change drawer Infinite ...
... is so bright many surgeons turn it down ... shift into when the going gets tough. More ... true Hot Start and the technologically advanced fan ... prevent failed start ups and overheating. The result ...
... start circuit extends life of lamp Reserve lamp ... model allows simultaneous use with a reserve lamp ... unit cool.Worldwide voltage and electrical certification Lamp ... lamp Easy access to lamp for quick ...
... Lawson Lite positions directly over one,eye ... the lens an exclusive feature ... fiber optic light that penetrates,deep into ... universal swivel mount enables the,surgeon to ...
Medicine Products: